Joel Isaacson & Co., LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 129 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Joel Isaacson & Co., LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2016$18,000
-5.3%
3,3500.0%0.00%0.0%
Q3 2016$19,000
+5.6%
3,3500.0%0.00%0.0%
Q2 2016$18,000
-28.0%
3,3500.0%0.00%
-33.3%
Q1 2016$25,000
-10.7%
3,3500.0%0.01%
-14.3%
Q4 2015$28,000
-6.7%
3,3500.0%0.01%
-12.5%
Q3 2015$30,000
-25.0%
3,3500.0%0.01%
-20.0%
Q2 2015$40,0003,3500.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2017
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders